This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
China’s Center for Drug Evaluation (CDE)
China’s Center for Drug Evaluation (CDE)
China’s Center for Drug Evaluation (CDE) is the executive arm within the National Medical Products Administration (NMPA) responsible for the technical evaluation of drugs. They handle the crucial tasks of reviewing and approving clinical trial applications, drug marketing authorization requests, and ensuring overall compliance with regulations.
In essence, the CDE acts as the gatekeeper for ensuring the safety and efficacy of new drugs entering the Chinese market.